Abbott (ABT) Wins FDA Approval for Healon EndoCoat Protective Gel for Cataract Surgery
Go back to Abbott (ABT) Wins FDA Approval for Healon EndoCoat Protective Gel for Cataract Surgery| Abbott Laboratories (NYSE: ABT) | Delayed: 116.64 +2.50 (2.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $114.14 | 52 Week High | $46.38 | |||
| Open | $114.02 | 52 Week Low | $36.00 | |||
| Day High | $116.66 | P/E | 77.76 | |||
| Day Low | $113.45 | EPS | $1.50 | |||
| Volume | 10,931,175 | |||||
